“Distribution of SALT Scores With Ritlecitinib Treatment up to 24 Months from the ALLEGRO Phase 2b 3 and Long-Term Phase 3 Clinical Studies in Alopecia Areata”. 2024. SKIN The Journal of Cutaneous Medicine 8 (6): s465. https://doi.org/10.25251/skin.8.supp.465.